BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16942844)

  • 1. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of absorption enhancers on nasal absorption of acyclovir.
    Chavanpatil MD; Vavia PR
    Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal drug delivery of sumatriptan succinate.
    Chavanpatil MD; Vavia PR
    Pharmazie; 2005 May; 60(5):347-9. PubMed ID: 15918583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
    Mei D; Mao S; Sun W; Wang Y; Kissel T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats.
    Na L; Mao S; Wang J; Sun W
    Int J Pharm; 2010 Sep; 397(1-2):59-66. PubMed ID: 20599486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
    du Plessis LH; Kotzé AF; Junginger HE
    Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats.
    Lu Y; Chen X; Du S; Wu Q; Yao Z; Zhai Y
    Arch Pharm Res; 2010 May; 33(5):691-6. PubMed ID: 20512466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
    Bortolotti F; Balducci AG; Sonvico F; Russo P; Colombo G
    Eur J Pharm Sci; 2009 Apr; 37(1):36-42. PubMed ID: 19162181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
    Zhang Y; Jiang XG; Yao J
    Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
    Khan SA; Patil KS; Yeole PG
    Pharmazie; 2008 May; 63(5):348-51. PubMed ID: 18557417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.